<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 102 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page101.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=102">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 102 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 102</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=102"><img src="../thumb/102.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Musculo-Skeletal Agents - 4.1.1                                                 2020-04 / 71
       NAFASOL, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  75 mg dly by deep intraglut.inj. Admin.2xdly.in sev./ hospital.pts.sepa-  Special precautions: Hypertens./HF hist., incr. adverse effs.in
       Naproxen.                     rat.by interv.of a few hrs.& admin.at diff.sites. Do not admin.by IV inj.  elderly which could be fatal, GI bleed. /perforat.risk high.with incr.
       Indications: Rheumat.& osteo arthrit., ankylos. spondylit., mild to   (S3) SUPPS, [P/S] 27/3.1/0121, Z/3.1/172, Y/3.1/395  dos., discont. treatm.if GI bleed./ulcerat./skin & hypersens. reacts./
       mod pain assoc.with musculo-skelet.disords., dysmenorrh.& gout.  Indications: Rheum.& osteo arthrit., ankylos. spondylit., post-trau-  vis.changes occur, GI dis.hist.incl.ulcerat. colit., not indic.for longt.
       (S3) EC TABS, [P/S] 27/3.1/0437, 0438.  mat.pain & inflamm., init.ther. for inflammat.& degenerat.rheumat.dis.  gout managem., asthma, bronchosp., bleed.disords., CV/collagen
       812625-005: 250 mg, 30, R49,55  807605-018: 12,5 mg, 5, R32,22  dis., liv./ ren. fail., CHF/cirrhos./diuret.-induc.vol.deplet./ ren. insuf-
       812625-013: 250 mg, 250, R413,01  807613-002: 25 mg, 5, R76,09  fic., HF precipit.in comprom.pts., coumarin anticoags., reg.use dur.3   rd
       812633-008: 500 mg, 30, R132,17  807621-005: 100 mg, 5, R67,06  trimest.of pregn.may result in persist.pulm.hypertens.of newborn &
       812633-016: 500 mg, 100, R440,54  Dosage: Never div.as ingred.poss.uneven distrib.  labour onset delay/incr.durat.
       Dosage: Swallow whole with food. Admin.low. effect. dos.for   Adults aver.dos: 100 mg each even. 12,5 mg & 25 mg: Childr.2 yrs   Drug interactions: Incr.S/E with concom.NSAID, incr.GI ulcerat./
       shortest durat.of treatm.     & more: 2-3 mg/kg bm dly in 2-3 fract. dos.  bleed.risk with corticoster., poss. enhanc. anticoag.eff., incr.GI bleed.
       Anti-rheumat: Adults: 500 mg-1 g dly.in 2 div. dos.  Contraindications: Porphyr., childr.und.2 yrs., hist./ act.GI bleed./  risk with anti-platel. agents & SSRI’s.
       Juvenile rheumatoid arthrit: Childr.over 5 yrs: 10 mg/kg bm.dly.  perforat.relat. to prev.NSAIDs, pept.ulcerat., act.or recurr.ulc./haem-
       in 2 div.dos.                 orrh./perforat. hist., sev.hepat./ren.impairm., aspir./any other NSAIDs   PIXICAM, Sandoz [P/S]
       Analges: Adults: Init. 500 mg follow.by 250 mg 6-8 hrly.  sens./hypersens., HF/est.ischaem.heart dis. &/ cerebrovasc.& periph.  Piroxicam.
       Gout: Init. 750 mg follow. by 250 mg 8 hrly.  arter.dis., pregn.& lactat, proctit.for supp. use.  Indications: Ankylos.spondylit., rheumat.& osteo-arthrit.,
       (S3) SUPPS, [P/S] Y/3.1/131.  Side effects: Oed., skin reacts.somet.fatal incl. exfol.dermatit./   ac.musculo-skelet.condits., ac.gout.
       Indications: Rheumat.& osteo arthrit., ankylos. spondylit., mild to   Stev. Johns.syndr./tox.epiderm. necrolys., decr. platel.aggregat.with   (S3) DISPERS.TABS. 29/3.1/0752.
       mod.pain assoc.with musculo-skelet.disords., dysmenorrh.& gout.  incr. bleed. time, GI disords.incl.pept.ulc./ bleed./perforat. somet.   827428-006: 20 mg, 30, R44,74
       810525-003: 500 mg, 10, R125,68  fatal, ulcer.stomatit., colit./Chron’s dis. xacerbat., card.disords.incl.  Dosage: Ankylos.spondylit., rheumat.& osteoarthrit: 20 mg dly.
       Dosage: Adults: 1 supp.PR at bedt.admin.in conjunct.with oral ther.  CF, vertigo, headache, tinnit., depress., drowsin., CNS eff., minor   although dos.of 10-30 mg dly. have been used.
       dur.the day. Tot.oral & rect.dos.not to exceed 1 g/day.  hear. disords., ocul.reacts., allerg./ naphylact.reacts., ren. & liv.im-  Ac.musculoskelet.disords: 7-14 days treatm. Init. 40 mg dly.x2
       Contraindications: Hist./act.GI bleed./pept. ulcerat., pregn.& lac-  pairm., bld.disords., dizzin.  days, then 20 mg dly.
       tat., aspir.& NSAID cross-sens., childr.und.16 yrs.except.in juven.  Warnings and special precautions: NSAID cross-sens. esp. where   Ac.gout: 40 mg dly.x5-7 days.
       rheumat. arthrit., heart fail.  prev.allerg.reacts.have been exhib., concom.methotrexate,hypertens.&/   Contraindications: Act pept.ulcerat., aspir./ NSAID cross-sens.,
       Side effects: GI disturb.& haemorrh., CNS eff., skin erupt., angioed.,   HF hist., HF precipit.in compromis.pts., signif.CV events risk fact., CV   asthmat.pts., urticar./ac.rhinit. precipit. by aspir./meds.with pros-
       vis.disturbs., incr.bleed.time, ren. impairm., bld.dyscras., poss.fluid re-  dis., bleed.disords., imp.ren./ hepat.funct., discont.ther.if GI ulcer./bleed.  tagland. synthetase inhibit.activ., pregn., lactat., childr.und. 12 yrs.
       tent.may precipit. HF in comprom.pts.  occurs/ if skin rash appears/mucos.les./hypersens.signs, condit. poss.  Side effects: GI disturbs.incl.GI haemorrh., CNS eff., hypersens.re-
       Special precautions: Asthma, bronchosp., bleed. disords., CV dis.,   exacerbat. in GI dis.hist., asthma/ bronchoconstrict., concom.coumarin   acts., asept.meningit., skin rash, Stev. John., erythema, itch., photos-
       ren.fail., concom.coumar anticoags., tabs.cont.lact.  anticoags., other concom.prot.bound meds., PUB risk high.with incr.   ens., tox. amblyop., card.disords., tinnit., pancreatit., hepatit., jaund.,
       Drug interactions: Poss.Li toxic.due to inhib.of clear., diuret.& an-  dos.in pts.with ulc.hist./elderly, reg.bld. counts dur.prolong.treatm., 25   bronchosp.in asthma pts., cystit., haematur., ac.ren.fail., interstit.ne-
       tihypertens.eff.of furosemide inhibit., poss.methotrex.toxic.due to   & 50 mg Tabs: not for lact.intol.pts.  phrit., nephrot. syndr., bld.dyscras., vis.disturbs.
       reduc.secret. of methotrex., coumar.OD poss.due to extens. bound.  Drug interactions: Poss.incr.methotrex.bld.conc., incr. S/E poss.with   Special precautions: Elderly, asthma, bleed. disords., bronchosp.,
       to plasma prot.               2 or more concurr.NSAIDs, other NSAID & glucocorticoids may aggrav.  pept.ulcerat.hist., liv./ ren. fail., CHF, cirrhos., CV/ collag.dis., diuret.-
                                                                  induc. vol. deplet./ ren.insuff.req.loc.synthes.of vasodilat. prosta-
                                     GI S/E, incr.PUB risk with corticoster., anticoags.effs.poss. enhanc.,
       NAPFLAM, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  antiplatel.& SSRI’s incr.GI bleed.risk, aspir. decr.plasma conc., incr.  gland. to maint.ren.perfus., discont.in vis. chang., may precipit.HF
       Naproxen.                     plasma conc.of Li & digox., half-life of probenecid incr.  in comprom.pts.
       Indications (S3): Rheumat.arthrit., osteo-arthros., ankylos.spon-  Drug interactions: Other concom.NSAID’s/ corticoster. incr.GI ul-
       dylit., ac.gout, ac.musc.-skelet. inflamm.disords., dysmenorrh., ju-  PEDEA, Equity [P/S] &  cerat.& bleed.risk, effs.of anticoags./ & thrombolyt.agents enhanc.,
       ven.rheumat. arthrit.         Ibuprofen.                   antiplatel. agents & SSRI’s poss.incr.GI bleed.risk, alcoh./ cortico-
       (S3) TABS. W/3.1/153, Z/3.1/65.  Indications: Haemodynam.signific.patent ductus .arteriosus in pre-  troph/K  supplem./valproic acid poss. incr.GI disturbs.risk, cyclospor.
                                                                      +
       806447-036: 250 mg, 250, R201,50  term newborn infts.of less than 28 wks.gestat.age  induc. nephrotoxic.
       808474-006: 500 mg, 30, R52,83  (S3) SOL FOR INJ, A40/3.1/0174
       808474-014: 500 mg, 100, R176,09  710969-001: 10 mg/2 ml, 4x2 ml amps, R7 450,51  PONSTAN, Pfizer Laboratories (Pty) Ltd
       Dosage: Admin.low.effect.dos.for shortest durat. of treatm.  Dosage: Admin.only by IV infus.over 15 mins. pref. undil.in neonat.  See Section 3.2
       Rheumat.arthrit., osteo-arthros., ankylos. spondylit: 500 mg-1 g/  intens.care und.supervis.of exper.neonatolog.  PYROCAPS, Ranbaxy [P/S]
                                                           st
       day in 2 div.dos.at 12 hr. interv.  Course of 3 dos.at 24 hr.interv.adjust.accord.to bm. 1  inj: 10 mg/  Piroxicam.
                                         rd
                                       nd
       Ac.gout: 750 mg immed.then 250 mg 8 hrly.  kg. 2  & 3  inj: 5 mg/kg. If ductus arteriosus does not close 48 hrs.  Indications: Rheumat.& osteo-arthrit., ankylos. spondylit.,
                                               nd
       Ac.musc.skelet.disords: 250 mg 2-3xdly. x7-14 days.  aft.last inj./ reopens a 2  course of 3 dos.may be admin. Surg.poss.  ac.musculo-skelet.disords., ac.gout.
                                                 nd
       Dysmenorrh: 500 mg init., then 250 mg 6-8 hrly.  necess.if condit.unchang.aft.2  course.  (S3) CAPS. 27/3.1/0187.
       Juven.arthrit.in childr over 5 yrs: 10 mg/kg bm/ day in 2 dos.at   Contraindications: Life threaten.infect., IC/GI haemorrh., thrombo-  799432-008: 20 mg, 30, R32,82
       12 hr.interv. Not recomm.for any other indicat.in childr.und.16 yrs.  cytopen/coagulat. defects, signific.imp.ren.funct., congenit.heart dis.  Dosage: Not for long-term managem.
       Contraindications: Pregn., lactat., act.pept. ulcerat., NSAID/aspir.  where ductus arteriosus patency necess.for satisfact. pulm./syst.bld.  Rheumat.& osteo-arthrit: 20 mg dly in sngl./div. dos.
       cross-sens., heart fail.      flow, known/suspect.necrotis. enterocolit.  Ac.musculoskelet.disords: 7-14 days treatm. Init. 40 mg dly.in
       Side effects: GI disturbs.incl.GI bleed., pept.ulc., skin rash, prurit.,   Side effects: Thrombocytopen., neutropen., intraventricul.haemorrh.,   sngl./div.dos. x2 days, then 20 mg dly.
       angio-oed., CNS eff., bld. dyscras., periph.oed., vis.disturbs., jaund.,   periventricul. leokomalac., bronchopulm.dysplas., pulm. haemorrh.,   Ac.gout: 40 mg x4-6 days.
       revers. ren.fail., neprhot.syndr., decr.platel.aggregat.& prolongs   hypoxaem., necrotis.enterocolit., intestin. perforat., GI haemorrh.,   Contraindications: Hepat.dysfunct., aspir./ NSAID cross-
       bleed.time, nephrit.          oligur., fluid retent., haematur.  sens., pept.ulc., GI bleed./ ulc.hist., safety in pregn./lactat./childr.
       Special precautions: GI dis., aspir.sens., bronch. asthma, allerg.  Warnings and special precautions: Perform. echocardiograph.   und.12 yrs.not est.
       dis., imp.ren./hepat.fail., elderly, compromis.card.funct., cont.lact.  examinat.prior to admin.to confirm diagnos.& excl.pulm.hypertens.&   Side effects: GI disturbs.incl.GI haemorrh., dermat., sens.reacts.,
       Drug interactions: Antihypertens.eff.of propranolol & poss.other ß-  ductul-depend.congenit.heart dis., not for prophylact. use, bilirub.en-  bld.dyscras., CNS eff., blurr. vis., tinnit., prurit., decr.platel.aggregat.&
       block reduc., natriuret. eff.of furosemide reduc., plasma Li conc.incr.,   cephalopathy risk incr.theref.do not use in mark.unconjugat.hyperbil-  prolong. bleed.time, oed., HF may be precipitat.in some comprom.pts.
       probenecid extends.its plasma half-life, poss. potent of hydantoins,   rubinaem., monit. for bleed./ren.& GI funct., S&S of infect.poss. mask.,   Special precautions: Ren.funct.impairm., coumar. type antico-
       anticoags.& other highly prot. bound.meds.  pres.of infect., avoid other concom. NSAID’s, withold next dos.till urine
                                     output norm. if anur./oligur.occurs.aft.1 /2  dos.  ags., GI haemorrh.
                                                     st
                                                      nd
       NUROFEN, Reckitt Benckiser Pharmaceuticals (Pty) Ltd  Drug interactions: Anticoag.eff.incr., reduc. excret. of some drugs   Drug interactions: Plasma Li lev.incr.
       See Section 3.2               due to effs.on ren.funct., incr. hyperkalaem.risk with ACE inhibit.&   RHEUGESIC, Cipla-Medpro [P/S]
                                     +
       PANAMOR, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  K -spar. diuret., antihypertens.eff.of some antihypertens. reduc.,   Piroxicam.
                                     other NSAID’s incr.advers.effs., incr.GI bleed. & ulcerat.risk with cor-
       Diclofenac sodium.            ticoster., incr. haemotox. with zidovud., plasma conc.incr.by ritonavir.  Indications: Ac.gout.emerg.treatm., post-traumat.condits.for
       Indications: Fev./mild to mod.pain of inflamm. orig. for max.5 days.  See also MDR page 312.  max.5 days.
       (S2) TABS, [P/S] R/3.1/49                                  (S2) DISPERS.TABS. 29/3.1/0302.
       752371-030: 25 mg, 15, R16,92  PIROXICAM ACTOR DT 20, (Actor Pharma) Cipla Medpro [P/S]  821144-015: 20 mg, 5, R12,40
       Dosage: Admin.low.effect.dos.for shortest treatm. durat. Swall.  Piroxicam.  821144-006: 20 mg, 30, R74,38
       whole.                        Indications: Condits.requir.anti-inflamm.&/ analges.act.incl. rheu-  Dosage: Admin. pref.with/aft.food. Use low. effect.dos.for short.
       25 mg 3x dly.for max 5 days with max.dos.75 mg/ day.  mat.& osteo-arthrit., ankylos. spondylit., ac.musculo-skelet.disords.,   poss.durat.
       (S2) TABS, [P/S] R/3.1/50     dysmenorrh., post-op pain, ac.gout.  Post traumat.condits: 1 tab.(20 mg) dly.for max.5 days.
       Indications: Ac.gout attack emerg.treatm.for max. 3 days  (S3) DISPERS.TABS. 34/3.1/0095  Ac.gout: 1 tab (20 mg) for max.5 days. Not for long-term managem.
       752398-114: 50 mg, 9, R5,29   716517-001: 20 mg, 30, R42,01  Contraindications: Prev.ser.allerg.drug react. hist. esp.cutan.reacts.,
       Dosage: Admin.low.effect.dos.for shortest treatm. durat. Swall.whole.  Dosage: Admin.low.effect.dos.for short.poss. durat.  prev.skin reacts to NSAID’s/ other meds, concom.anticoags., safety in
       50 mg 3x dly.for max 3 days with max.dos.150 mg/ day.  Ankylos.spondylit., rheumat.& osteoarthrit: Init.20 mg as sngl.  pregn./ lactat./ porphyr./childr.und.12 yrs.not est., aspir./NSAID cross-
       (S3) SR TABS, [P/S] 29/3.1/0121, 0122.  dly.dos. Maint: 20 mg dly. Up to 30 mg giv.dly as sngl./ div.dos. if requir.  sens., GI bleed./perforat.hist. relat.to prev.NSAID, act./hist.of recurr.
       Indications: Rheum.& osteo-arthrit., ankylos. spondylit., post-traum.  Ac.musculoskelet.disords: Init. 40 mg dly.for 1  2 days as sngl./  ulc./ haemorrh., HF, GI dis.hist. predispos.to bleed. disords., dyspeps.,
                                                          st
       pain & inflamm., symptomat.treatm.of prim. dysmenorrh.  div.dos.follow.by 20 mg dly.for 1-2 wks  liv./kidn.disords., bld.dyscras./ haemorrh. diathes./uncontr.hypertens.,
       827584-008: 75 mg, 30, R155,89  Ac.gout: Init.40 mg dly.as sngl.dos.follow.by 40 mg as sngl./div.dly.  other concom. NSAID incl.COX-2 select.NSAID/ acetylsalicyl. acid.
       827592-019: 100 mg, 28, R132,46  dos.for next 4-6 days.    Side effects: Fluid retent., oed., decr.platel. aggregat./ bleed.time
       Dosage: Admin.pref.with meals without break./chew. Init.dly dos:   Dysmenorrh: Init.recomm.dos: 40 mg giv.as dly. dos. for 1  2 days at   prolong., GI disturbs.incl.GI haemorrh.somet.fatal/Chron’s dis., bld.
                                                             st
       100-150 mg admin.as 100 mg as sngl.dos or 150 mg in 2 div.dos. Mild   sympt.onset thereaft.sngl.dly. dos.of 20 mg as need.  dyscras., pancreatit., hypersens.reacts.incl.hepatoxic.& asept. men-
       cases & long term ther: 75 mg dly.usual.suffic. 100 mg tab.giv.in   Contraindications: Aspir.sens., GI haemorrh./ perfor.hist.relat.to   ingit., anaphylax., bronchosp.in asthma pts., angioneurot.oed., vas-
       even. where sympt.more mark. dur. night or in morn.  prev.NSAID, act./hist.of recurr. ulc., HF, safety in pregn.& lactat./  culit., ser.sickn., hypo-/hyperglycaem., weight chang., psych.disords.,
       (S3) INJ, [P/S] W/3.1/52.     porphyr./childr. und.12 yrs. not est.  headache, dizzin., paraesthes., CNS effs., vis. disturbs. incl.tox.am-
       Indications: Init.ther.for inflamm.degen.rheumat. dis., painf.inflamm.  Side effects: Oed.& fluid retent., poss.GI dis. exacerbat., skin reacts.  blop., tinnit., vertigo, hear. abnormalit., palpit., CHF, ac.HF, oed., hy-
       condits.of non-rheum.origin, ac.gout attacks.  somet.fatal incl.exfoliat. dermatit./ Stev. John.syndr./tox.epiderm.   pertens., shock, dysnpn., epistax., hepatotoxic., jaund., fatal hepatit.,
       780111-001: 75 mg/3 ml, 5x3 ml, R21,03  necrolys., GI disturbs.incl.haemorrh.somet.fatal, CNS eff., headache,   skin reacts.incl.Stev.Johns syndr./tox. epiderm. necrolys./onycholys./
       780111-028: 75 mg/3 ml, 50x3 ml, R210,34  dizzin., tinnit., CV disords. incl.CF, hypertens., hypersens.reacts., bron-  photosens., alopec., cystit., haematur., ac.ren.fail., interstit.nephrit.,
       Dosage: Not to be giv. for long. than a few days, contin. with oral   chosp. in asthma pts., cystit., haematur., ac.ren.fail., interstit.nephrit.,   nephrot. syndr., asthen., malaise, HF precipit.in comprom. pts., hiat.
       ther.if necess.               nephrot.syndr., bld.dyscras., vis. disturbs.  hern./GORD exacerbat., poss. female fertil.impairm.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page101.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page97.html">97</a>&nbsp;&nbsp;&nbsp;<a href="page98.html">98</a>&nbsp;&nbsp;&nbsp;<a href="page99.html">99</a>&nbsp;&nbsp;&nbsp;<a href="page100.html">100</a>&nbsp;&nbsp;&nbsp;<a href="page101.html">101</a>&nbsp;&nbsp;&nbsp;<a href="page102.html">102</a>&nbsp;&nbsp;&nbsp;<a href="page103.html">103</a>&nbsp;&nbsp;&nbsp;<a href="page104.html">104</a>&nbsp;&nbsp;&nbsp;<a href="page105.html">105</a>&nbsp;&nbsp;&nbsp;<a href="page106.html">106</a>&nbsp;&nbsp;&nbsp;<a href="page107.html">107</a>
             </td>
             <td width="35%"><a href="page103.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page103.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
